# Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials

Article · Nicholas J. Viney, Julian C. van Capelleveen, Richard S. Geary, Shuting Xia, Joseph A. Tami, Rosie Z. Yu, Santica M. Marcovina, Steven G. Hughes, Mark J. Graham, Rosanne M. Crooke, Stanley T. Crooke, Joseph Lee Witztum, Erik S.G. Stroes, Sotirios Tsimikas

- Archive id: doi:10.1016/s0140-6736(16)31009-1
- Published: 2016-09-21
- Venue: The Lancet
- DOI: https://doi.org/10.1016/s0140-6736(16)31009-1
- PMID: 27665230
- Citations: 753
- Source URL: https://doi.org/10.1016/s0140-6736(16)31009-1
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [Cardiovascular Therapeutics](https://space-kitty.com/topics/cardiovascular-innovation)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.